SARS-CoV

CAS No.	Product Name	Inquiry
	1"-α-Azido-RDPr
	28-O-Imidazolyl-azepano-betulin
	2'-RIBOTAC-U
	AMY-101 acetate AMY-101 acetate inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 acetate exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation.
	AMY-101-acetate AMY-101 acetate (Cp40 acetate), a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs). AMY-101 acetate (Cp40 acetate) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation.
	Ansabananin Ansabananin is a weak inhibitor of the ATPase activity of the SARS Coronavirus helicase, with an IC50 value of 51 μM.
	Anti-MERS-2E6-mAb Anti-MERS-2E6 mAb, a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells.
	Anti-MERS-3A1-mAb Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells. Anti-MERS-3A1 mAb bocks the binding of MERS-CoV spike protein to DPP4 receptor.
	Antimicrobial agent-10
	Antimicrobial agent-11
	Antimicrobial agent-12
1070773-09-9	RK-33 RK-33 is a first-in-class inhibitor of DDX3. It causes G1 cell cycle arrest, induces apoptosis, and promotes radiation sensitization in DDX3-overexpressing cells, which has therapeutic use in cancers.
1005304-44-8	SARS-CoV-2-nsp13-IN-1 SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent nsp13 (non-structural protein 13) inhibitor. SARS-CoV-2 nsp13-IN-1 only inhibits nsp13 ssDNA+ ATPase, with an IC50 of 6 μM. SARS-CoV-2 nsp13-IN-1 does not inhibit ssDNA- ATPase. SARS-CoV-2 nsp13-IN-1 can be used for COVID-19 research.
1015582-31-6	SARS-CoV-2-nsp13-IN-3 SARS-CoV-2 nsp13-IN-3 (Compound C3) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 32 μM against nsp13 ssDNA+ ATPase.
1016762-41-6	SARS-CoV-2-IN-89
1017691-52-9	SARS-CoV-2-IN-31
1029939-86-3	Artefenomel Artefenomel (OZ439) is an orally active, synthetic anti-malarial compound containing an artemisinin pharmacophore with a mechanism of action similar to that of artemisinin. Artefenomel has antiviral activity against SARS-CoV-2.
10371-86-5	SMU-CX1
104494-35-1	Kazinol F
1052540-65-4	Debrisoquin hydroiodide Debrisoquin is an adrenergic neuron-blocking drug similar in effects to guanethidine. It is an antihypertensive drug with antioxidant, anti-inflammatory, and neuroprotective properties. It can regulate the activity of certain neurotransmitters, including dopamine and serotonin, which makes it a promising candidate for treating neurological disorders, such as Parkinson's disease and depression.

※ Please kindly note that our services are for research use only.